| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sreenivasa Rao Sudulagunta, Mahesh Babu Sodalagunta, Hadi Khorram, Mona Sepehrar, Mohammed Aheta Sham, Ranjitha Nidsale Sudarshan, Rekha Gangadharapp. Neuromyelitis optica (NMO) and autoimmune thyroiditis. Oxford medical case reports. vol 2015. issue 10. 2015-11-16. PMID:26568836. |
neuromyelitis optica (nmo or devic's syndrome) is a rare demyelinating disease of the cns that predominantly affects the spinal cord and optic nerves and shares many clinical and radiological features with multiple sclerosis (ms). |
2015-11-16 |
2023-08-13 |
Not clear |
| H Yokote, Y Nose, S Ishibashi, K Tanaka, T Takahashi, K Fujihara, T Yokota, H Mizusaw. Spinal cord ring enhancement in patients with neuromyelitis optica. Acta neurologica Scandinavica. vol 132. issue 1. 2015-11-10. PMID:25639599. |
clinical and pathological significance of gadolinium (gd)-enhancing pattern on magnetic resonance imaging (mri), including ring enhancement (re), is well documented in multiple sclerosis but not in neuromyelitis optica (nmo), especially in the spinal cord. |
2015-11-10 |
2023-08-13 |
Not clear |
| b' Iva Ga\\xc5\\xa1parovi\\xc4\\x87, Nada Star\\xc4\\x8devi\\xc4\\x87 \\xc4\\x8cizmarevi\\xc4\\x87, Luca Lovre\\xc4\\x8di\\xc4\\x87, Olivio Perkovi\\xc4\\x87, Polona Lavtar, Juraj Sep\\xc4\\x8di\\xc4\\x87, Sa\\xc5\\xa1a \\xc5\\xa0ega Jazbec, Miljenko Kapovi\\xc4\\x87, Borut Peterlin, Smiljana Risti\\xc4\\x8. MMP-2 -1575G/A polymorphism modifies the onset of optic neuritis as a first presenting symptom in MS? Journal of neuroimmunology. vol 286. 2015-11-10. PMID:26298319.' |
previous studies show altered activities of matrix metalloproteinase (mmp)-2 and mmp-9 in serum and cerebrospinal fluid of multiple sclerosis (ms) and neuromyelitis optica (nmo) patients. |
2015-11-10 |
2023-08-13 |
Not clear |
| Atanu Biswas, Arabinda Mukherje. Therapy of NMO spectrum disorders. Annals of Indian Academy of Neurology. vol 18. issue Suppl 1. 2015-11-05. PMID:26538843. |
neuromyelitis optica (nmo) is an autoimmune demyelinating condition of the central nervous system often associated with aquaporin-4 (aqp4) autoantibodies manifesting as severe optic neuritis and long segment myelitis with tendency to relapse. |
2015-11-05 |
2023-08-13 |
Not clear |
| Megan M Langille, Jay Desa. Multisystem involvement in neuromyelitis optica. Annals of Indian Academy of Neurology. vol 18. issue Suppl 1. 2015-11-05. PMID:26538850. |
we describe a case of pediatric neuromyelitis optica (nmo) with muscle and lung involvement in addition to central nervous system disease. |
2015-11-05 |
2023-08-13 |
Not clear |
| Prompan Mingbunjerdsuk, Bashar Katirj. Acute cervical segmental denervation in neuromyelitis optica spectrum disorder. Journal of clinical neuromuscular disease. vol 16. issue 2. 2015-11-04. PMID:25415521. |
neuromyelitis optica (nmo) is an inflammatory demyelinating disease of central nervous system. |
2015-11-04 |
2023-08-13 |
Not clear |
| M Muto, M Mori, Y Sato, A Uzawa, S Masuda, T Uchida, S Kuwabar. Current symptomatology in multiple sclerosis and neuromyelitis optica. European journal of neurology. vol 22. issue 2. 2015-11-03. PMID:25264295. |
neuromyelitis optica (nmo) is another inflammatory disease of the central nervous system, and most of the opticospinal form of ms is thought to be nmo. |
2015-11-03 |
2023-08-13 |
Not clear |
| Xavier Ayrignac, Clarisse Carra Dalière, Elodie Nerrant, Thierry Vincent, Jérôme De Seze, Pierre Labaug. Extensive cerebral white matter involvement in a patient with NMO spectrum disorder. Multiple sclerosis (Houndmills, Basingstoke, England). vol 20. issue 10. 2015-10-27. PMID:24852925. |
we report the case of a 49-year-old woman with long-lasting neuromyelitis optica (nmo) spectrum disorder and diffuse cerebral white matter t2-weighted hyperintensities. |
2015-10-27 |
2023-08-13 |
Not clear |
| Reza Khorooshi, Nasrin Asgari, Marlene Thorsen Mørch, Carsten Tue Berg, Trevor Owen. Hypersensitivity Responses in the Central Nervous System. Frontiers in immunology. vol 6. 2015-10-27. PMID:26500654. |
serum-derived autoantibodies with predominant specificity for the astrocyte water channel aquaporin-4 (aqp4) are implicated as inducers of pathology in neuromyelitis optica (nmo), a central nervous system (cns) demyelinating disease where activated neutrophils infiltrate, unlike in ms. |
2015-10-27 |
2023-08-13 |
mouse |
| Ju-Hong Min, Patrick Waters, Angela Vincent, Hye-Jin Cho, Byung-Euk Joo, Sook-Young Woo, Soo-Youn Lee, Hee-Young Shin, Kwang Ho Lee, Byoung Joon Ki. Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability. PloS one. vol 9. issue 9. 2015-10-26. PMID:25211011. |
vitamin d may play a role in neuromyelitis optica (nmo) or nmo spectrum disorder (nmosd), as an important factor involved in immunological pathways. |
2015-10-26 |
2023-08-13 |
Not clear |
| Mohammad Hossein Harirchian, Abbas Tafakhori, Shervin Taslimi, Vajiheh Aghamollaii, Reza Shahsiah, Taha Gholipour, Fatemezahra Mohammadi, Ameneh Zare-Shahabad. Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience. Iranian journal of allergy, asthma, and immunology. vol 14. issue 1. 2015-10-26. PMID:25530145. |
seroprevalence of nmo-igg antibody in neuromyelitis optica (nmo) and its specificity in differentiating nmo from other demyelinating diseases with overlap symptoms: an iranian experience. |
2015-10-26 |
2023-08-13 |
human |
| Hongjuan Jia, Jing Ye, Xiaoling Zhao, Feifei He, Kuncheng Li, Yaou Li. [A clinical analysis of onset of high-risk demyelinating events in patients with neuromyelitis optica]. Zhonghua nei ke za zhi. vol 54. issue 4. 2015-10-22. PMID:26268061. |
to explore the clinical characteristics of the lesions of spinal cord and optic nerve as the onset of neuromyelitis optica (nmo). |
2015-10-22 |
2023-08-13 |
Not clear |
| Eduardo Freitas, Joana Guimarãe. Neuromyelitis optica spectrum disorders associated with other autoimmune diseases. Rheumatology international. vol 35. issue 2. 2015-10-21. PMID:24952418. |
neuromyelitis optica (nmo) is an inflammatory demyelinating autoimmune disease with severe, tremendously incapacitating, consequences in the patient's health and wellbeing. |
2015-10-21 |
2023-08-13 |
Not clear |
| Rohan Mandaliya, Margot Boigon, David G Smith, Suchit Bhutani, Naveed Ali, Cheryl Hilton, John Kelly, Nataliya Ternopolsk. A diagnostic challenge in a young woman with intractable hiccups and vomiting: a case of neuromyelitis optica. Journal of community hospital internal medicine perspectives. vol 5. issue 5. 2015-10-21. PMID:26486116. |
these symptoms are usually not appreciated as the possible initial manifestation of neuromyelitis optica (nmo). |
2015-10-21 |
2023-08-13 |
Not clear |
| Jun-ichi Kir. [My way to "Keep Pioneering": integrated neuroscience and immunology research produces a paradigm shift for intractable neurological disease]. Rinsho shinkeigaku = Clinical neurology. vol 54. issue 12. 2015-10-19. PMID:25672676. |
in ms, i propose that th1/th17 cell-mediated connexin astrocytopathy may play a critical role in producing huge demyelinating lesions in ms, neuromyelitis optica (nmo), and baló's concentric sclerosis. |
2015-10-19 |
2023-08-13 |
mouse |
| Masahiro Mor. [Novel therapeutic target in neuromyelitis optica and multiple sclerosis: high mobility group box 1 (HMGB1)]. Rinsho shinkeigaku = Clinical neurology. vol 54. issue 12. 2015-10-19. PMID:25672684. |
we have reported that hmgb1 concentrations were elevated in cerebrospinal fluid (csf) from patients with neuromyelitis optica (nmo) and multiple sclerosis (ms) and that the elevation was significant in csf from nmo patients. |
2015-10-19 |
2023-08-13 |
mouse |
| Katsuichi Miyamot. [Topics of neuromyelitis optica]. Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology. vol 37. issue 6. 2015-10-19. PMID:25748131. |
neuromyelitis optica (nmo) has been revealed the difference in the pathology of multiple sclerosis since the anti-aquaporin 4 (aqp4) antibody associated with nmo has been found. |
2015-10-19 |
2023-08-13 |
Not clear |
| Wei Qiu, Yanyu Chang, Rui Li, Youming Long, Jianhua Huang, Weihua Mai, Xiaobo Sun, Zhengqi Lu, Xueqiang H. [Correlation of AQP4 gene polymorphism with NMO clinical phenotypes and its underlying mechanism]. Zhonghua yi xue za zhi. vol 95. issue 7. 2015-10-19. PMID:25916924. |
to explore the correlation between aquaporin-4 (aqp4) gene single nucleotide polymorphism (snp) and clinical phenotypes of neuromyelitis optica (nmo) and its underlying mechanism. |
2015-10-19 |
2023-08-13 |
Not clear |
| Joseph R Berger, Janna Neltner, Charles Smith, Franca Camb. Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica. Multiple sclerosis and related disorders. vol 3. issue 6. 2015-10-15. PMID:25891552. |
we report on a 42 year old woman with neuromyelitis optica (nmo) of 10 years duration who developed extensive white matter disease affecting chiefly both parietal lobes 6 months after her first and only dose of rituximab. |
2015-10-15 |
2023-08-13 |
Not clear |
| Masahiro Mor. [Association between Multiple Sclerosis or Neuromyelitis Optica and Epstein-Barr Virus]. Brain and nerve = Shinkei kenkyu no shinpo. vol 67. issue 7. 2015-10-09. PMID:26160816. |
meanwhile, the association between neuromyelitis optica (nmo) and infectious agents has been reported, but is currently unclear. |
2015-10-09 |
2023-08-13 |
Not clear |